Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Significance of Circulating T Regulatory Cells , Soluble CD25 and CXCL9 to Assess Disease Activity of Vitiligo.

NCT05569096 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05569096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05569096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Significance of Circulating T Regulatory Cells , Soluble CD25 and CXCL9 to Assess Disease Activity of Vitiligo.
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2024
Completion date
January 31, 2026
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cd25 deficiency, chemokine (c-x-c motif), tregs, vitiligo